{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T19:45:20Z","timestamp":1791402320020,"version":"4.3.3"},"reference-count":23,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2006,8,1]],"date-time":"2006-08-01T00:00:00Z","timestamp":1154390400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,12,16]],"date-time":"2019-12-16T00:00:00Z","timestamp":1576454400000},"content-version":"vor","delay-in-days":4885,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Annals of Oncology"],"published-print":{"date-parts":[[2006,8]]},"DOI":"10.1093\/annonc\/mdl128","type":"journal-article","created":{"date-parts":[[2006,6,10]],"date-time":"2006-06-10T00:39:26Z","timestamp":1149899966000},"page":"1306-1312","source":"Crossref","is-referenced-by-count":95,"title":["Low-dose liposomal amphotericin B in the prevention of invasive fungal infections in patients with prolonged neutropenia: results from a randomized, single-center trial"],"prefix":"10.1016","volume":"17","author":[{"given":"O.","family":"Penack","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Schwartz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Martus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Reinwald","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Schmidt-Hieber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Thiel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I.W.","family":"Blau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1093\/annonc\/mdl128_bb0010","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1056\/NEJM199203263261301","article-title":"A controlled trial of fluconazole to prevent fungal infections in patients undergoing bone marrow transplantation","volume":"326","author":"Goodman","year":"1992","journal-title":"N Engl J Med"},{"key":"10.1093\/annonc\/mdl128_bb0015","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1007\/s10156-002-0207-5","article-title":"Itraconazole is not effective for the prophylaxis of fungal infections in patients with neutropenia","volume":"9","author":"Kaptan","year":"2003","journal-title":"J Infect Chemother"},{"key":"10.1093\/annonc\/mdl128_bb0020","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1086\/515128","article-title":"Randomized placebo-controlled trial of fluconazole prophylaxis for neutropenic cancer patients: benefit based on purpose and intensity of cytotoxic therapy. The Canadian Fluconazole Prophylaxis Study Group","volume":"28","author":"Rotstein","year":"1999","journal-title":"Clin Infect Dis"},{"key":"10.1093\/annonc\/mdl128_bb0025","doi-asserted-by":"crossref","first-page":"705","DOI":"10.7326\/0003-4819-138-9-200305060-00006","article-title":"Intravenous and oral itraconazole versus intravenous and oral fluconazole for long-term antifungal prophylaxis in allogeneic hematopoietic stem-cell transplant recipients. A multicenter, randomized trial","volume":"138","author":"Winston","year":"2003","journal-title":"Ann Intern Med"},{"key":"10.1093\/annonc\/mdl128_bb0030","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1136\/pgmj.71.835.284","article-title":"Prophylactic use of fluconazole in neutropenic cancer patients","volume":"71","author":"Yamac","year":"1995","journal-title":"Postgrad Med J"},{"key":"10.1093\/annonc\/mdl128_bb0035","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1086\/321805","article-title":"Summary of the guidelines for preventing opportunistic infections among hematopoietic stem cell transplant recipients","volume":"33","author":"Dykewicz","year":"2001","journal-title":"Clin Infect Dis"},{"issue":"2","key":"10.1093\/annonc\/mdl128_bb0040","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1038\/sj.bmt.1701543","article-title":"Liposomal amphotericin (AmBisome) in the prophylaxis of fungal infections in neutropenic patients: a randomised, double-blind, placebo-controlled study","volume":"23","author":"Kelsey","year":"1999","journal-title":"Bone Marrow Transplant"},{"key":"10.1093\/annonc\/mdl128_bb0045","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1086\/515129","volume":"28","author":"Menichetti","year":"1999","journal-title":"Clin Infect Dis"},{"key":"10.1093\/annonc\/mdl128_bb0050","first-page":"901","article-title":"A randomized controlled trial of itraconazole versus fluconazole for the prevention of fungal infections in patients with haematological malignancies","volume":"105","author":"Morgenstern","year":"1999","journal-title":"U.K. Multicentre Antifungal Prophylaxis Study Group. Br J Haematol"},{"key":"10.1093\/annonc\/mdl128_bb0055","doi-asserted-by":"crossref","first-page":"2327","DOI":"10.1128\/AAC.44.9.2327-2332.2000","article-title":"Single-dose AmBisome (Liposomal amphotericin B) as prophylaxis for murine systemic candidiasis and histoplasmosis","volume":"44","author":"Garcia","year":"2000","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1093\/annonc\/mdl128_bb0060","first-page":"1195","article-title":"Prophylaxis with liposomal amphotericin B (AmBisome) prevents fungal infections in liver transplant recipients: long-term results of a randomized, placebo-controlled trial","volume":"27","author":"Tollemar","year":"1995","journal-title":"Transplant Proc"},{"key":"10.1093\/annonc\/mdl128_bb0065","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1097\/00007890-199501150-00009","article-title":"Liposomal amphotericin B prevents invasive fungal infections in liver transplant recipients. A randomized, placebo-controlled study","volume":"59","author":"Tollemar","year":"1995","journal-title":"Transplantation"},{"key":"10.1093\/annonc\/mdl128_bb0070","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1086\/323335","article-title":"Defining opportunistic invasive fungal infections in immunocompromised patients with cancer and hematopoietic stem cell transplants: an international consensus","volume":"34","author":"Ascioglu","year":"2002","journal-title":"Clin Infect Dis"},{"key":"10.1093\/annonc\/mdl128_bb0075","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1093\/biomet\/73.1.13","article-title":"Longitudinal data-analysis using generalized linear-models","volume":"73","author":"Liang","year":"1986","journal-title":"Biometrika"},{"key":"10.1093\/annonc\/mdl128_bb0080","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/S0167-9473(97)83562-1","article-title":"MAREG and WinMAREG a tool for marginal regression models","volume":"24","author":"Kastner","year":"1997","journal-title":"Comput Statis Data Analy"},{"key":"10.1093\/annonc\/mdl128_bb0085","doi-asserted-by":"crossref","first-page":"3365","DOI":"10.1182\/blood-2002-05-1356","article-title":"Evidence-based assessment of primary antifungal prophylaxis in patients with hematologic malignancies","volume":"101","author":"Cornely","year":"2003","journal-title":"Blood"},{"key":"10.1093\/annonc\/mdl128_bb0090","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1093\/jac\/48.1.97","article-title":"Itraconazole versus amphotericin B plus nystatin in the prophylaxis of fungal infections in neutropenic cancer patients","volume":"48","author":"Boogaerts","year":"2001","journal-title":"J Antimicrob Chemother"},{"key":"10.1093\/annonc\/mdl128_bb0095","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1111\/j.1600-0609.2004.00239.x","article-title":"Low-dose amphotericin B lipid complex vs. conventional amphotericin B for empirical antifungal therapy of neutropenic fever in patients with hematologic malignancies\u2013a randomized, controlled trial","volume":"72","author":"Subira","year":"2004","journal-title":"Eur J Haematol"},{"key":"10.1093\/annonc\/mdl128_bb0100","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1111\/j.1439-0507.1992.tb00850.x","article-title":"Tyden G. A retrospective clinical comparison between antifungal treatment with liposomal amphotericin B (AmBisome) and conventional amphotericin B in transplant recipients","volume":"35","author":"Tollemar","year":"1992","journal-title":"Mycoses"},{"key":"10.1093\/annonc\/mdl128_bb0105","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1038\/sj.bmt.1702233","article-title":"Fluconazole vs low-dose amphotericin B for the prevention of fungal infections in patients undergoing bone marrow transplantation: a study of the North American Marrow Transplant Group","volume":"25","author":"Wolff","year":"2000","journal-title":"Bone Marrow Transplant"},{"key":"10.1093\/annonc\/mdl128_bb0110","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1002\/cncr.11936","article-title":"Amphotericin B lipid complex as prophylaxis of invasive fungal infections in patients with acute myelogenous leukemia and myelodysplastic syndrome undergoing induction chemotherapy","volume":"100","author":"Mattiuzzi","year":"2004","journal-title":"Cancer"},{"key":"10.1093\/annonc\/mdl128_bb0115","first-page":"577","article-title":"Randomized double-blind study of liposomal amphotericin B (Ambisome) prophylaxis of invasive fungal infections in bone marrow transplant recipients","volume":"12","author":"Tollemar","year":"1993","journal-title":"Bone Marrow Transplant"},{"key":"10.1093\/annonc\/mdl128_bb0120","doi-asserted-by":"crossref","first-page":"353","DOI":"10.3109\/10428199309067926","article-title":"Efficacy of itraconazole in the prevention of fungal infections among neutropenic patients with hematologic malignancies and intensive chemotherapy. A double blind, placebo controlled study","volume":"11","author":"Vreugdenhil","year":"1993","journal-title":"Leuk Lymphoma"}],"container-title":["Annals of Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0923753419476230?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0923753419476230?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/academic.oup.com\/annonc\/article-pdf\/17\/8\/1306\/417994\/mdl128.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,2,20]],"date-time":"2020-02-20T16:54:03Z","timestamp":1582217643000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0923753419476230"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,8]]},"references-count":23,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2006,8]]}},"alternative-id":["S0923753419476230"],"URL":"https:\/\/doi.org\/10.1093\/annonc\/mdl128","relation":{},"ISSN":["0923-7534"],"issn-type":[{"value":"0923-7534","type":"print"}],"subject":[],"published":{"date-parts":[[2006,8]]}}}